NLX

(5A,17R)-4,5-EPOXY-3,14-DIHYDROXY-17-METHYL-6-OXO-17-(2-PROPENYL)-MORPHINANIUM

Created:	2002-10-24
Last modified:	2021-03-01

Find Related PDB Entry
1 entries where NLX is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	1
Atom Count	49
Chiral Atom Count	5
Bond Count	53
Aromatic Bond Count	6

2D diagram of NLX

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(5A,17R)-4,5-EPOXY-3,14-DIHYDROXY-17-METHYL-6-OXO-17-(2-PROPENYL)-MORPHINANIUM
Synonyms	N-METHYLNALOXONIUM
Systematic Name (OpenEye OEToolkits)	(3R,4R,4aS,7aR,12bS)-3-methyl-4a,9-bis(oxidanyl)-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-3-ium-7-one
Formula	C₂₀ H₂₄ N O₄
Molecular Weight	342.409
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C5C3Oc1c2c(ccc1O)CC4C(O)(C23CC[N+]4(C)C/C=C)CC5
SMILES	CACTVS	3.385	C[N+]1(CC[C]23[CH]4Oc5c(O)ccc(C[CH]1[C]2(O)CCC4=O)c35)CC=C
SMILES	OpenEye OEToolkits	1.7.6	C[N+]1(CCC23c4c5ccc(c4OC2C(=O)CCC3(C1C5)O)O)CC=C
Canonical SMILES	CACTVS	3.385	C[N@+]1(CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@]2(O)CCC4=O)c35)CC=C
Canonical SMILES	OpenEye OEToolkits	1.7.6	C[N@@+]1(CC[C@]23c4c5ccc(c4O[C@H]2C(=O)CC[C@]3([C@H]1C5)O)O)CC=C
InChI	InChI	1.03	InChI=1S/C20H23NO4/c1-3-9-21(2)10-8-19-16-12-4-5-13(22)17(16)25-18(19)14(23)6-7-20(19,24)15(21)11-12/h3-5,15,18,24H,1,6-11H2,2H3/p+1/t15-,18+,19+,20-,21-/m1/s1
InChIKey	InChI	1.03	PCSQOABIHJXZMR-YNUHATHGSA-O

Drug Info: DrugBank

DrugBank ID	DB04509
Name	N-Methylnaloxonium
Groups	experimental
Synonyms	N-Methylnaloxonium

Related Resource References

Resource Name	Reference
PubChem	6323452

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.